# Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder

> **NCT02570282** · PHASE2 · COMPLETED · sponsor: **Strategic Science & Technologies, LLC** · enrollment: 31 (actual)

## Conditions studied

- Sexual Arousal Disorder

## Interventions

- **DRUG:** Placebo
- **DRUG:** SST-6007

## Key facts

- **NCT ID:** NCT02570282
- **Lead sponsor:** Strategic Science & Technologies, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-09
- **Primary completion:** 2017-05
- **Final completion:** 2017-07
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2017-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02570282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02570282, "Study to Evaluate the Efficacy and Safety of SST-6007, a Topical Sildenafil Cream, Compared to Placebo in Women With Female Sexual Arousal Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02570282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*